Dry Powder Inhaler (DPI) Joins CanNegev Incubator in Yeruham

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email



CanNegev is pleased to announce that Dry Powder Inhaler (DPI) has joined the CanNegev Incubator program. This follows approval by the Israel Innovation Authority (IAA).

CanDI DPI is a breakthrough in delivering medications and cannabinoids to the lungs by dry powder inhalator. Suitable for any generic and systemic medical powder drugsEasy to use for all patients.

We wish CanDI every success!